ClinicalTrials.gg
CompletedNCT03414424Updated Nov 29, 2023Results posted

Non-invasive Cervical Electrical Stimulation for SCI

An interventional study of CES at rest and CES plus active hand or wrist movements in Spinal Cord Injuries, sponsored by Bronx VA Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-29.

Sponsored by Bronx VA Medical Center · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Aug 2017, registered Jan 2018).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 968 studies in Spinal Cord Injuries with a site in United States — 249 open to participants now, 308 under way, 7 of them phase 3. Spinal Cord Injuries · United States.

Enrollment
320th of 836
30 · median 24
Started
2017
with 56 others
No phase
601 of 968
189 open now
Registered
430th of 968
by date

Among the 968 studies in Spinal Cord Injuries with a site in United States, this one is the 320th largest by enrollment of the 836 interventional ones that give a count, is one of 57 that started in 2017, is one of 601 with no phase, and was the 430th registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

249 of the 968 studies in Spinal Cord Injuries with a site in United States are open now. Recruiting first, the newest first:

244 more — sign in →

All 249 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 968 studies in Spinal Cord Injuries with a site in United States, or all of them as a file.
02

Study summary

Most spinal cord injuries (SCI) are anatomically incomplete - some nerve circuits remain intact, even if the individual cannot feel or control them. Activating spared nerve circuits may improve functional recovery.

With this goal, the Investigators have developed a form of electrical stimulation over the cervical spinal cord that can activate muscles in both hands simultaneously and comfortably. This technique, called cervical electrical stimulation (CES), works at the skin surface - no surgery or other invasive procedures are required.

The long-term goal is to use CES to strengthen residual circuits to hand muscles after SCI. Regaining control over hand function represents the top priority for individuals with cervical SCI.

In the current study, the Investigators first need to better understand how CES works. In the first half of this study, the Investigators will take a systematic approach to determining how CES interacts with other circuits in the spinal cord and the brain. In the second half of the study, the Investigators will test combinations of CES with active hand and wrist movements to find ways to enhance physical movement with CES.

These experiments will improve understanding of electrical stimulation in SCI, and may set the table for future treatments to prolong any short-term benefits observed in this study.

Read the detailed description

Roughly 60% of spinal cord injuries occur at the cervical level. Most injuries are anatomically incomplete. Activating spared nerve circuits augments functional recovery of the damaged nervous system. With this goal, the Investigators have developed a novel method of non-invasive cervical electrical stimulation (CES). Preliminary data show that CES triggers afferent sensory or efferent motor nerve roots depending on stimulus intensity, resulting in concurrent activation of multiple muscles on both upper limbs. the Investigators aim to use CES to strengthen residual circuits to hand muscles after SCI. Regaining control over hand function represents the top priority for individuals with cervical SCI.

However, much more work needs to be done to better understand underlying CES mechanisms, its interactions with segmental and supraspinal circuits, and its optimal stimulation parameters for improving neural transmission to the hands. This proposal will address these issues.

Mechanistic experiments: 15 able-bodied volunteers and 15 subjects with motor-incomplete cervical spinal cord injury will undergo systematic combinations of CES with transcranial magnetic stimulation (TMS) or peripheral nerve stimuli at varying intensities, sites, and interstimulus intervals.

Mechanistic hypotheses: Conditioning subthreshold CES pulses will potentiate responses to test pulses of TMS and peripheral nerve F-wave stimulation, will reduce responses to test pulses of peripheral nerve H-reflex stimulation, and will modulate response to test suprathreshold CES pulses in either direction depending on conditioning stimulus interval and intensity. These experiments will elucidate CES circuit interactions at both the segmental and supraspinal levels.

Combined CES-volitional movement experiments: 15 able-bodied volunteers and 15 subjects with motor-incomplete cervical spinal cord injury will undergo systematic combinations of CES with volitional wrist and hand movements at varying intensity and effort level.

Combined CES-volitional movement hypotheses: Conditioning subthreshold CES pulses will facilitate concurrent volitional wrist and hand muscle activation. Suprathreshold CES will transiently inhibit concurrent volitional wrist and hand muscle activation. These experiments will shed light on the clinically relevant possibility of using CES to enhance response to physical exercise therapy.

Completion of the proposed studies will characterize CES circuit timing and distribution, and will demonstrate in principle the potential for CES to enhance physical therapy for wrist and hand muscles. Furthermore, this approach is compatible with other interventions, including drug and cell-based treatments.

03

Conditions studied

  • Spinal Cord Injuries

Keywords

  • transcutaneous electric nerve stimulation
  • transcranial magnetic stimulation
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 and 75 years;
  • Chronic (more than 12 months since injury) incomplete SCI between levels C2-C8.
  • Incomplete weakness of left or right hand muscles: score of 2, 3, or 4 (out of 5) on manual muscle testing of finger extension, finger flexion, or finger abduction;
  • Detectable F-wave responses of the left or right abductor pollicis brevis muscle to median nerve stimulation.
  • US Veteran or non-Veteran

Exclusion criteria

Exclusion Criteria:

  • History of other serious injury or disease of central or peripheral nervous system
  • History of seizures
  • Ventilator dependence or patent tracheostomy site
  • Use of medications that significantly lower seizure threshold
  • History of head trauma with evidence of brain contusion or hemorrhage or depressed skull fracture on prior imaging
  • History of implanted:

    • brain/spine/nerve stimulators
    • aneurysm clips
    • ferromagnetic metallic implants
    • or cardiac pacemaker/defibrillator
  • Significant coronary artery or cardiac conduction disease
  • Recent history (within past 6 months) of recurrent autonomic dysreflexia, defined as a syndrome of sudden rise in systolic pressure greater than 20 mm Hg (millimeters of mercury) or diastolic pressure greater than 10 mm Hg, without rise in heart rate, accompanied by symptoms such as headache, facial flushing, sweating, nasal congestion, and blurry vision (this will be closely monitored during all screening and testing procedures);
  • History of bipolar disorder or suicide attempt or active psychosis
  • Heavy alcohol consumption (> equivalent of 5 ounces of liquor) within previous 48 hours
  • Open skin lesions over the face, neck, shoulders, or arms
  • Pregnancy
  • Unsuitable for study participation as determined by study physician
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    All subjects

    All subjects undergo same full protocol, including CES at rest and CES plus active hand or wrist movements.

    Device: CES at rest · Device: CES plus active hand or wrist movements

Interventions

  • DeviceCES at rest

    CES will be delivered at rest at various intensities, in combination with either electrical stimulation over peripheral nerves or magnetic stimulation over the motor cortex. This is an experiment designed to measure CES interactions with other central and peripheral nerve circuits.

  • DeviceCES plus active hand or wrist movements

    CES will be delivered while the participant performs specific finger or wrist tasks at different degrees of effort. This is an experiment designed to detect momentary changes in muscle function.

06

What researchers measure

Primary outcomes

  1. Electromyographic Responses (Active)

    Effect of cervical electrical stimulation (CES) on concurrent finger or wrist active movements will be measured via root-mean-square of ongoing muscle activity in various hand and forearm muscles.

    Time frame: up to one day

  2. Electromyographic Responses to Transcranial Magnetic and Cervical Electrical Stimulation at Rest

    Response of the target hand muscle to transcranial magnetic stimulation (delivered at 120% of resting motor threshold) with or without a conditioning cervical electrical stimulator pulse (delivered at 90% of resting motor threshold) timed to arrive at cervical synapses 2 milliseconds after transcranial pulse arrival. Response is expressed as percentage change relative to the response to unconditioned transcranial magnetic stimulation.

    Time frame: up to one day

07

Results

Posted Nov 29, 2023
Limitations and caveats
Data collection for the active condition (cervical electrical stimulation during active muscle contraction) was plagued with technical problems, not possible to quantitatively analyze.

Participant flow

Participant flow — Overall Study
MilestoneAble BodiedSpinal Cord Injured
Started1515
Completed1512
Not completed03
Withdrew: Screened out after consent02
Withdrew: Lost to follow-up01

Outcome measures

PrimaryElectromyographic Responses (Active)

Effect of cervical electrical stimulation (CES) on concurrent finger or wrist active movements will be measured via root-mean-square of ongoing muscle activity in various hand and forearm muscles.

Time frame:
up to one day

No measurements were reported for this outcome.

PrimaryElectromyographic Responses to Transcranial Magnetic and Cervical Electrical Stimulation at Rest

Response of the target hand muscle to transcranial magnetic stimulation (delivered at 120% of resting motor threshold) with or without a conditioning cervical electrical stimulator pulse (delivered at 90% of resting motor threshold) timed to arrive at cervical synapses 2 milliseconds after transcranial pulse arrival. Response is expressed as percentage change relative to the response to unconditioned transcranial magnetic stimulation.

Time frame:
up to one day
Reported as:
Mean · % change from unconditioned TMS.
Electromyographic Responses to Transcranial Magnetic and Cervical Electrical Stimulation at Rest
% change from unconditioned TMS.Able-bodiedSpinal Cord Injury
Electromyographic Responses to Transcranial Magnetic and Cervical Electrical Stimulation at Rest6.1 ± 8.932.0 ± 27.8

Adverse events

Collected over 1 week. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Able-bodied0/15 (0%)0/15 (0%)7/15 (46.7%)
Spinal Cord Injury0/15 (0%)0/15 (0%)7/15 (46.7%)
Most frequent other events
Most frequent other events
EventAble-bodiedSpinal Cord Injury
Scalp pain/HeadacheNervous system disorders3/153/15
Neck painMusculoskeletal and connective tissue disorders2/153/15
Metallic tasteNervous system disorders2/150/15
Trouble concentratingPsychiatric disorders2/150/15
SleepyGeneral disorders0/151/15
Depressed moodPsychiatric disorders1/150/15
ParesthesiasNervous system disorders1/150/15
Light-headedGeneral disorders0/151/15

Baseline characteristics

Age, Continuous
Age, Continuous(years)Able BodiedSpinal Cord InjuredTotal
Mean38.7 ± 15.047.5 ± 15.443.1 ± 15.6
Sex: Female, Male
Sex: Female, Male(Participants)Able BodiedSpinal Cord InjuredTotal
Female347
Male121123
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Able BodiedSpinal Cord InjuredTotal
Hispanic or Latino224
Not Hispanic or Latino111223
Unknown or Not Reported213
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Able BodiedSpinal Cord InjuredTotal
American Indian or Alaska Native000
Asian022
Native Hawaiian or Other Pacific Islander000
Black or African American729
White61016
More than one race000
Unknown or Not Reported213
Region of Enrollment
Region of Enrollment(participants)Able BodiedSpinal Cord InjuredTotal
United States151530
08

Study locations

1 site
  • James J. Peters VA Medical Center, Bronx, NY
    Bronx, New York 10468, United States
09

References and documents

Publications

  • Wu YK, Levine JM, Wecht JR, Maher MT, LiMonta JM, Saeed S, Santiago TM, Bailey E, Kastuar S, Guber KS, Yung L, Weir JP, Carmel JB, Harel NY. Posteroanterior cervical transcutaneous spinal stimulation targets ventral and dorsal nerve roots. Clin Neurophysiol. 2020 Feb;131(2):451-460. doi: 10.1016/j.clinph.2019.11.056. Epub 2019 Dec 13. PubMed 31887616 ↗
  • Wecht JR, Savage WM, Famodimu GO, Mendez GA, Levine JM, Maher MT, Weir JP, Wecht JM, Carmel JB, Wu YK, Harel NY. Posteroanterior Cervical Transcutaneous Spinal Cord Stimulation: Interactions with Cortical and Peripheral Nerve Stimulation. J Clin Med. 2021 Nov 15;10(22):5304. doi: 10.3390/jcm10225304. PubMed 34830584 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — A Limited Dataset (LDS), with individual electrophysiological and physiological outcome measures, will be shared in electronic format pursuant to a VA-approved Data Use Agreement. Individually Identifiable Data will be shared pursuant to valid HIPAA Authorization, Informed Consent, and an appropriate written agreement limiting use of the data to the conditions as described in the authorization and consent, and a written assurance from the recipient that the information will be maintained in accordance with the security requirements of 38 CFR Part 1.466.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: At time of publication

Access criteria: A Limited Dataset (LDS) will be shared in electronic format pursuant to a VA-approved Data Use Agreement. Individually Identifiable Data will be shared pursuant to valid HIPAA Authorization, Informed Consent, and an appropriate written agreement limiting use of the data to the conditions as described in the authorization and consent, and a written assurance from the recipient that the information will be maintained in accordance with the security requirements of 38 CFR Part 1.466.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2017 to primary completion in Apr 2021, 44 months.

Results were first posted in Nov 2023, 2 years 6 months after primary completion.

Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's 44 months is above that.

Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 16, 2018
First posted
Jan 30, 2018
StartActual
Aug 22, 2017
Primary completionActual
Apr 30, 2021
CompletionActual
Apr 30, 2021
Results first posted
Nov 29, 2023
Last update
Nov 29, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 29, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03414424
Lead sponsor
Bronx VA Medical Center
Responsible party
Noam Y. Harel (Principal Investigator, Bronx VA Medical Center) — Principal investigator
First posted
Jan 30, 2018
Start date
Aug 22, 2017
Primary completion
Apr 30, 2021
Completion
Apr 30, 2021
Results posted
Nov 29, 2023
Last update
Nov 29, 2023

Study contacts

Noam Y. Harel, MD, PhD
principal investigator · Bronx VA Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion